Company Announcements

Roadshow Announcement

Source: RNS
RNS Number : 7329Z
Litigation Capital Management Ltd
15 January 2024
 

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the European Economic Area or in any other jurisdiction where it is unlawful to distribute this document. 

UK MiFIR retail investors, professional investors and ECPs target market - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients (all distribution channels) and also retail clients (all distribution channels).

  15 January 2024

LITIGATION CAPITAL MANAGEMENT LIMITED

Roadshow Announcement

Litigation Capital Management Limited, an alternative asset manager specialising in providing disputes financing solutions, today announces a roadshow to meet with professional fixed income investors.

A sterling bond may follow, subject to market conditions.

For further information, please contact:

Litigation Capital Management Limited via Tavistock
Patrick Moloney, Chief Executive Officer


Allia C&C

Mark Glowrey


Telephone:

+44 (0)20 3039 3465

 

Tavistock
Tim Pearson

Katie Hopkins

Telephone:

+44 (0)20 7920 3150

Email:

lcm@tavistock.co.uk

 

Canaccord (Nomad and Joint Broker) 
Bobbie Hilliam

Telephone:

+44 (0)20 7523 8000

 

Investec Bank plc (Joint Broker)
David Anderson

Telephone:

+44 (0)20 7597 5970

 


IMPORTANT INFORMATION

The distribution of this announcement and other information in connection with any offer in certain jurisdictions may be restricted by law and persons who come into possession of this announcement or any document or other information referred to herein should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any securities.

Any securities referred to herein will not be registered under the U.S. Securities Act of 1933, as amended, (the "Securities Act"). Subject to certain exceptions, such securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons.

Any securities referred to herein are expected to be offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA (the "UK Prospectus Regulation"). Any offer and sale of any securities will be made in compliance with the requirements of the UK Prospectus Regulation.

This announcement is directed only at persons who (i) are outside the United Kingdom or (ii) have professional experience in matters relating to investments or (iii) are persons falling within Article 49 (2)(a) to (d) of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iv) any other persons to whom this announcement may lawfully be communicated pursuant to the Order (all such persons together being referred to as "relevant persons"). This announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVRORSKUAAAR